Feasibility of Therapy With Hypomethylating Agents in Patients With Renal Insufficiency-Reference-Cited by-同舟云学术

Feasibility of Therapy With Hypomethylating Agents in Patients With Renal Insufficiency

Published:2010-06 Issue:3 Volume:10 Page:205-210
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Batty G. Nicolas,Kantarjian Hagop,Issa Jean-Pierre,Jabbour Elias,Santos Fabio P.S.,McCue Deborah,Garcia-Manero Guillermo,Pierce Sherry,O'Brien Susan,Cortés Jorge E.,Ravandi Farhad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the Cancer and Leukemia Group B;Silverman;J Clin Oncol,2002

2. Azacitidine (AZA) treatment prolongs overall survival (OS) in higher-risk MDS patients compared with conventional cure regimens (CCR): results of the AZA-001 phase III study;Fenaux;Blood,2007

3. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study;Kantarjian;Cancer,2006

4. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia;Kantarjian;Blood,2007

5. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells;Rhee;Nature,2002

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administration of combined venetoclax and azacitidine in a patient with acute myeloid leukemia and multiple comorbidities undergoing dialysis: A case report;eJHaem;2023-06-06

2. Hypomethylating agent-based therapies in older adults with acute myeloid leukemia – A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee;Journal of Geriatric Oncology;2023-04

3. Epigenetic modification of gene expression in cancer cells by terahertz demethylation;Scientific Reports;2023-03-26

4. Chemotherapy;Medicines for Cancer;2023

5. Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience;Cancers;2022-10-06